The Claim
In C57BL/6 mice exposed to the neurotoxin MPTP, daily administration of caffeine at 10 mg/kg reduces striatal dopamine depletion by a factor of 2.5 compared to untreated controls, and this effect is associated with adenosine A2A receptor blockade.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice treated with a toxin that mimics Parkinson's disease, daily caffeine at a specific dose prevents a 2.5-fold loss of dopamine in a brain region critical for movement, and this protection is linked to the blocking of adenosine A2A receptors.
See the scientific wording
In C57BL/6 mice exposed to the neurotoxin MPTP, daily caffeine administration at 10 mg/kg significantly attenuated striatal dopamine depletion by 2.5-fold compared to untreated controls, suggesting adenosine A2A receptor blockade may protect dopaminergic neurons in a Parkinson's disease model.
Caffeine blocks a specific brain receptor that normally increases activity in a neural circuit that overstimulates dopamine-producing cells. By blocking this receptor, the circuit becomes less active, which reduces excessive signaling that would otherwise damage and kill those dopamine cells, allowing them to survive even when exposed to a toxic chemical.
What the research says
1 studyIn mice given a poison that kills brain cells that make dopamine, caffeine helped protect those cells — and it worked because it blocked a specific brain receptor called A2A. This suggests coffee might help protect against Parkinson’s disease in a similar way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.